Form D · Other Energy
OPX Biotechnologies Inc
Boulder, CO · CIK 0001403916
Offering snapshot reported Jul 5, 2011 · SEC filing
- Reported sold
- $36.5M Offering amount: $45M
- Investors reported
- 6 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jun 24, 2011 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 5, 2011 | Initial | $36,499,996 | No comparison | 6 | SEC filing |
| Sep 10, 2010 | Initial | $50,788 | No comparison | 0 | SEC filing |
| Jan 14, 2009 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Nov 6, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Jun 13, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-162282
Source: Form D, filed Jul 5, 2011. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Robert Chess | Director |
| Charles R. Eggert | Director, Executive |
| Steve Foster | Director |
| Ryan Gill | Director |
| Jonathan Koch | Director |
| William D. Lese | Director |
| Michael D. Lynch | Executive |
| Daniel W. Muehl | Executive |
| Cory Steffeck | Director |
| Erik Straser | Director |
Issuer details
Industry: Other Energy (See others in industry)
Address:
2425 55 Th Street, Suite 100
Boulder, CO, 80301
Boulder, CO, 80301